Important timelines Flashcards

1
Q

If informed consent is not feasible and the investigator does not have enough time to consult, how long do they have to get the decision reviewed and evaluated by an outside physician?

A

5 working days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

If informed consent is not feasible, how long does the investigator have to submit documentation to the IRB?

A

5 working days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When does emergency use of a test article need to be reported to the IRB?

A

5 working days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How often does IRB registration need to be renewed?

A

Every 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How quickly does an IRB need to submit changes to contact or chair person’s information?

A

90 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How quickly does an IRB need to report its decision to review new types of FDA-regulated products OR discontinue reviewing clinical investigations regulated by the FDA?

A

30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How quickly does an IRB need to report its decision to disband?

A

30 days after permanent cessation of IRB’s review of research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How often shall an IRB conduct a continuing review of research?

A

At least once a year, more if the level of risk requires it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How long should an IRB keep required records?

A

3 years, need to be accessible by the FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How often should information amendments to the IND be submitted?

A

As necessary, but not more than once every 30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How quickly should an IND safety report be submitted to the FDA?

A

ASAP, no later than 15 calendar days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When does additional information requested by the FDA for an IND safety report need to be submitted?

A

ASAP, no later than 15 calendar days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When does the sponsor need to notify the FDA of an unexpected, fatal, or life threatening suspected adverse reaction by?

A

ASAP, no later than 7 calendar days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When should an annual report be submitted for an IND?

A

Within 60 days of the anniversary date the IND went into effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How long does the ICH require the sponsor retain essential documents for after the last approval of a marketing application in an ICH region and until there are no pending or contemplated marketing applications in an ICH region?

A

At least 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Under 21 CFR 812, How often should the current investigator list be submitted to the FDA?

A

A current list of the names and addresses of all investigators participating in the investigation are submitted to FDA at six (6)-month intervals starting from the date of approval.

17
Q

How quickly should unanticipated adverse device effects (UADEs) be submitted to the FDA?

A

within 10 working days after sponsor receives notice of the effects

18
Q

When should a final study report be submitted to the FDA?

A

A final study report is to be submitted to the FDA within six (6) months after the study is completed.